None listed
Conditions
Interventions
Intervention1: Nil: Nil
Control Intervention1: Nil: Nil
Sponsors
E. Ragadharshini
Eligibility
Inclusion criteria
Inclusion criteria: Presenting with concerns of hair loss or scalp abnormalities. Willing to provide consent for scalp imaging and participation in the study. No previous diagnosis or treatment for AGA.
Exclusion criteria
Exclusion criteria: Previous treatments for AGA (e.g., minoxidil or finasteride) within the last six months. Any skin condition that may interfere with scalp imaging (e.g., active psoriasis, eczema). Unwillingness to Participate: Patients unwilling to participate in the study or to give informed consent. Experimental Treatments: Patients enrolled in other clinical trials for experimental hair loss treatments may be excluded to prevent confounding factors.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Demonstrate high sensitivity and specificity in detecting early AGA, improving diagnostic accuracy. Reduce the time required for dermatologists to interpret trichoscopic images. Improve the consistency of diagnoses between dermatologists, reducing variability in clinical decision-making. Enable early intervention and treatment of AGA, resulting in better patient outcomes, especially in cases where early signs of hair thinning are subtle. Timepoint: 1 week | — |
Secondary
| Measure | Time frame |
|---|---|
| To make the diagnosis of early Androgenetic alopecia easier. A study tool for all budding dermatologists.Timepoint: ;To make the diagnosis of early Androgenetic alopecia easier. A study tool for all budding dermatologists.Timepoint: 4 weeks | — |
Countries
India
Contacts
Public ContactVarun Rajagopal
Saveetha medical college and hospital, Saveetha institute of medical and technical sciences
Outcome results
None listed